Evidence map›Paper›PMID 40129187›Full record

ArticleACS applied materials & interfaces2025

Curcuminoid-Based Responsive Surfaces for Fluorescent BF

Raquel Gimeno-Muñoz, Raúl Díaz-Torres, Silvia Gómez-Coca, Olivier Roubeau, José Manuel Díaz-Cruz, Núria Aliaga-Alcalde, Arántzazu González-Campo

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Boron-/nitrogen-doped TiRSC advances · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Raquel Gimeno-MuñozInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus de La Universitat Autonoma de Barcelona, Barcelona 08193, Spain.
Raúl Díaz-TorresInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus de La Universitat Autonoma de Barcelona, Barcelona 08193, Spain.
Silvia Gómez-CocaDepartament de Química Inorgànica and Institut de Recerca de Química Teòrica I Computacional, Universitat de Barcelona (UB), Diagonal 645, Barcelona 08028, Spain.
Olivier RoubeauInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC and Universidad de Zaragoza, Plaza San Francisco s/n, Zaragoza 50009, Spain.ORCID 0000-0003-2095-5843
José Manuel Díaz-CruzDepartament d'Enginyeria Química I Química Analítica, Universitat de Barcelona (UB), Diagonal 645, Barcelona 08028, Spain.ORCID 0000-0001-8241-3463
Núria Aliaga-AlcaldeInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus de La Universitat Autonoma de Barcelona, Barcelona 08193, Spain.ORCID 0000-0003-1080-3862
Arántzazu González-CampoInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus de La Universitat Autonoma de Barcelona, Barcelona 08193, Spain.ORCID 0000-0002-1209-8119

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The strategic design of a novel curcuminoid (CCMoid), termed PA, containing pyrene units and a terminal carboxylic group provides the necessary tools for its efficient immobilization on surfaces and its potential use as an optical chemosensor. To this end, our work provides a robust methodology for the preparation of CCMoid-based active surfaces with a fluorescent response and reusability. The covalent immobilization of the CCMoid is obtained by the reaction of the acidic groups of PA and the imidazole ends of the previously functionalized substrates. In this way, fluorescent patterned surfaces of PA, whose emission could be observed in the visible region thanks to the pyrene groups of the CCMoid, were obtained using microcontact printing. In addition, the coordination of BF

Indexed as

active materialsBF3chemosensorscurcumin derivativescurcuminoidsfluorescenceresponsive surfaces

Identifiers

PMID40129187
PMCPMC11969430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.